相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
4°C, protect from light
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
301177-43-5
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1050.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥613.0 |
| 规格: | 5 mg | 产品价格: | ¥1350.0 |
| 规格: | 10 mg | 产品价格: | ¥2250.0 |
| 规格: | 25 mg | 产品价格: | ¥4950.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
ESI-08
CAS No. : 301177-43-5
MCE 国际站:ESI-08
产品活性:ESI-08 是一种有效的选择性 EPAC 拮抗剂,可以完全抑制 EPAC1 和 EPAC2 (IC50 为 8.4 μM) 的活性。ESI-08 选择性阻断 cAMP 诱导的 EPAC 激活,但不抑制 cAMP 介导的 PKA 激活。
研究领域:GPCR/G Protein
作用靶点:Ras
In Vitro: Exchange proteins directly activated by cAMP (EPAC) are a family of guanine nucleotide exchange factors that regulate a wide variety of intracellular processes in response to second messenger cAMP. ESI-08 at 25 μM has been found not to alter cAMP-induced type I and II PKA holoenzymes activation while H89, a selective PKA inhibitor, blocked the type I or II PKA activities completely.
相关产品:Covalent Screening Library Plus | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Kinase Inhibitor Library | Anti-Cancer Compound Library | Covalent Screening Library | Anti-Cardiovascular Disease Compound Library | Ferroptosis Compound Library | Glutamine Metabolism Compound Library | Anti-Pancreatic Cancer Compound Library | Angiogenesis-Related Compound Library | Anti-Liver Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Sotorasib | MRTX1133 | Adagrasib | BI-2852 | BI-3406 | Ketoconazole | NSC 23766 trihydrochloride | BI-2865 | ML141 | BAY-293 | CID-1067700 | Rhosin hydrochloride | Lonafarnib | EHT 1864 | GGTI298 Trifluoroacetate | MBQ-167 | MRTX0902 | Opnurasib | Divarasib | ARS-1620 | CCG-1423 | CASIN | Salirasib | EHop-016 | RMC-6291 | ML-098 | MRTX-1257 | FTI-277 hydrochloride | Pan-RAS-IN-1
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验2.60 2.51 2.45 2.28 2.08 1.84 8.10 5.85 4.94 4.43 4.10 3.87 3.70 3.56 3.23 2.86 2.42 30 4.17 3.32 2.92 2.69 2.53 2.42 2.33 2.27 2.09 1.89 1.62 7.56 5.39 4.51 4.02 3.70 3.47 3.30 3.17 2.84 2.47 2.01 40 4.08 3.23 2.84 2.61 2.45 2.34 2.25 2.18 2.00
0.351.08±0.15(0.8-2.05)132±16.4110±12.5(80.0-165)15.0±4.9013.9±3.20(5.00-23.9)0.55±0.110.42±0.10(0.20-0.90)147±2.20146±1.90(139-153)4.54±1.104.42±0.20(3.60-5.20)114±1.15111±1.20(103-121)21.8±3.6022.2±2.91(14.6-29.4)4.40±1.003.60±0.50(2.60-5.60)10.2±0.429
Crystallization of Kinesin Family Motor Proteins
.,2001; Nitta et al.,2004); the Kinesin-5 (formerly BimC)motor,monomeric Eg5 (Turner et al.,2001); and the Kinesin-13 (formerly MCAK)motor,PfKinI (Shipley et al.,2004).The following tables summarize the crystallization conditions and some of the crystal
技术资料暂无技术资料 索取技术资料


















